IXICO partner with Microsoft to enhance AI platform
October 20, 2021Research and Development
IXICO, an AI data analytics company delivering insights into neuroscience, have announced a collaboration with Microsoft to develop its AI …
Synairgen COVID-19 treatment moves to Phase III trials
October 20, 2021Research and Development
Synairgen PLC have said that its anti-viral treatment for severe lung infections is advancing to the final stage of clinical …
Pharma Innovation Award given to Stevanato Group for AI-ready vision Robot Unit
October 20, 2021Research and Development
Stevanato Group, a global provider of processes and services for the Pharmaceutical and Healthcare industry, has been announced as a …
UK COVID deaths highest since March – Doctors call for urgent return of restrictions
October 20, 2021Research and Development
Medical professionals in the NHS have urgently pleaded the UK government to reimpose COVID restrictions as UK COVID deaths reach …
England care staff shortage puts thousands at risk
October 20, 2021Research and Development
Managers of community care services for over 15,000 people in England say that staff shortages have led to them turning …
Hyloris announces approval of new drug for pain management
October 19, 2021Manufacturing and Production
Specialist biopharma company Hyloris has announced the further extension of the European footprint of Maxigesic® IV, which is a novel …
National Institutes of Health to evaluate Enesi Pharma’s Implavax®-enabled flu vaccines
October 19, 2021Manufacturing and Production
Enesi Pharma, a pioneering biotechnology company, has entered an agreement with the US National Insitutes of Health’s (NIH) National Institute …
Lipocine and Antares Pharma enter agreement to commercialise TLANDO®
October 19, 2021Manufacturing and Production
Clinical-stage biopharmaceutical company, Lipocine Inc, has announced that it has entered an exclusive licensing agreement with Antares Pharma Inc to …
Global Heart Hub and Novartis form partnership to combat ASCVD
October 19, 2021Manufacturing and Production
Global Heart Hub and Novartis have announced the launch of a joint programme to bring together a worldwide network of …
Survey reveals efficacy of Pfizer and AstraZeneca vaccines against positive COVID-19 tests
October 18, 2021Sales and Marketing
Data from the Coronavirus Infection Survey (CIS), and pillars 1 and 2 of the NHS Test and Trace have measured …
MindMaze and The Royal Buckinghamshire Hospital create brain repair platform
October 18, 2021Sales and Marketing
MindMaze Healthcare, major leader in the multi billion-dollar digital neurotherapeutics market, has announced the first UK partnership for its MindPod™ …
Major trial proposes how to reduce ICU infections caused by staphylococcus aureus
October 18, 2021Sales and Marketing
A major US hospital-based clinical trial has highlighted the benefit of using nasal decolonisation to reduce ICU infections caused by …
Valneva COVID-19 vaccine shown to be more effective than AstraZeneca candidate
October 18, 2021Sales and Marketing
French biotech company, Valneva, has announced positive results from the Phase III trial of its inactivated, adjuvanted COVID-19 vaccine candidate, …
First Indian anti-cancer drug launches in China
October 15, 2021Medical Communications
The first Indian anti-cancer drug, Abiraterone Acetate API, has launched in China, by Dr Reddy’s Laboratories. This breakthrough was announced …
FDA approves emergency booster dose of Moderna’s COVID-19 vaccine
October 15, 2021Medical Communications
The FDA Advisory Committee has unanimously voted in support of emergency use for a booster dose of Moderna’s COVID-19 vaccine …
EMA begins real-time review of AstraZeneca’s COVID antibody cocktail
October 15, 2021Medical Communications
The human medicines committee of the EMA has begun the rolling review of AstraZeneca’s antibody-based COVID-19 therapy, the first protective …
Abbott Labs recalls two COVID test kits after false positives
October 15, 2021Medical Communications
A unit of Abbott Laboratories is recalling two COVID-19 lab test kits over concerns they can potentially issue false positives, …
Anticancer Bioscience receives additional $10.6m investment into cancer therapy
October 14, 2021Business Services
Precision oncology company, Anticancer Bioscience (ACB), has announced that it has secured an additional $10.6 million from Chinese investors. The …
Lexeo Therapeutics and FUJIFILM announce partnership to co-develop gene therapies
October 14, 2021Business Services
LEXEO Therapeutics, clinical-stage gene therapy company, and FUJIFILM Diosynth Biotechnologies, world leading CDMO for biologics, viral vaccines and viral vectors, …
WHO’s new taskforce “last chance” to track COVID origins
October 14, 2021Business Services
The WHO has put together a new taskforce, the Scientific Advisory Group on the Origins of Novel Pathogens (Sago), with …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
